Professional Documents
Culture Documents
Daily Equity Report
Daily Equity Report
HEADLINES
Indian Market
Indian equity markets up by 0.77% Nifty up by 45.75 pts and settle at 5950.85 Sensex up by 154.10 pts at 19580.81 Bank Nifty up by 179.90 pts at 12654.15
Global Market
European markets were closed with FTSE ,CAC and DAX remained closed . Dow future was up 269.00 closed at 13046.00
HEADLINES
Our profit margin will come down in FY14 & FY15: Shriram MD Have already factored in 25 bps repo rate cut in Jan Glenmark gains on USFDA nod for diarrhoea drug Govt offers 17 coal blocks to PSUs, invites proposals
WWW.EPICRESEARCH.CO
09752199966
MARKET ANALYSIS:
Key benchmark indices edged higher on first trading day of calendar 2013. The BSE Sensex was down 26.74 points or 0.14% to 19,418.10. The market breadth, indicating the overall health of the market, was strong. The market sentiment was boosted by the US Senate approving an agreement early on Tuesday struck hours earlier by the White House and Senate Republicans to keep the world's biggest economy from falling off the fiscal cliff. The BSE Sensex was up 154.37 points or 0.79% to 19,581.08. The S&P CNX Nifty was up 44.85 points or 0.76% to 5,949.95. Among the 30-share Sensex pack, 27 gained while only three of them declined In the auto pack, Mahindra & Mahindra rose after the company said during trading hours today, 1 January 2013 its auto sales rose 6% in December 2012 over in December 2011. Pidilite Industries hit a record high. Among the 30-share Sensex pack, 27 gained while only three of them declined. Bank stocks gained on fresh buying. India's largest private sector bank by net profit ICICI Bank advanced 2.15% to Rs 1,161.70.
FII DII
1-Jan-13 1-Jan-13
885.51 857.63
220.46 1263.77
665.05 -406.14
SUZLON
WWW.EPICRESEARCH.CO
09752199966
EXPERT OPINION
NIFTY
Nifty looks Consolidate Strategy: Sell on rise Support: 5900 Resistance: 6000
BANK NIFTY
Bank Nifty looks Consolidate Strategy: Sell on rise Support: 12580 Resistance: 12720 .0
2.43 2.26
PREVIOUS PERFORMANCE
TYPE SCRIP B/S RESULT
S B B S
CASH FUTURE
09752199966
MARKET CALLS
CASH
SCRIPS AURO PHARMA ICICI BANK ACTION BUY BUY LEVEL 194.00 204.00 1
ST
ND
FUTURE
SCRIPS . REC MCLEOD RUSELL BUY SELL 251.75 354.20 253.75 352.20 256.75 349.20 249.75 356.20 ACTION LEVEL 1
ST
TARGET
ND
TARGET
STOP LOSS
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not a ccept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.